Lacosamide Fresenius Kabi

Lacosamide, the active ingredient in Lacosamide Fresenius Kabi, is an anti‑epileptic presented as an intravenous solution for intravenous use. It treats partial‑onset seizures and is used as adjunctive therapy in epilepsy patients.

GNH USA supplies Lacosamide Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lacosamide is an anticonvulsant indicated for seizure disorders. - Partial‑onset seizures: reduces seizure frequency when added to existing therapy. - Adjunctive therapy for epilepsy: improves overall seizure control in patients with refractory epilepsy. - Focal seizures with secondary generalization: provides additional seizure control as part of combination therapy.

Lacosamide may cause a range of adverse reactions.

Common Side Effects: - Dizziness - Nausea - Headache - Fatigue

Serious or Rare Side Effects: - Cardiac conduction abnormalities (e.g., PR‑interval prolongation) - Severe skin reactions such as Stevens‑Johnson syndrome - Suicidal ideation or behavior

When using Lacosamide, several safety considerations are recommended. - Monitor cardiac function: obtain baseline ECG and repeat as clinically indicated. - Assess renal function: adjust therapy in patients with significant renal impairment. - Evaluate psychiatric status: watch for depression or suicidal thoughts. - Review concomitant medications: avoid or carefully manage drugs that also affect cardiac conduction. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lacosamide can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Co‑administration with other sodium‑channel blockers (e.g., carbamazepine) may increase cardiac risk. - Strong CYP3A4 inhibitors (e.g., ketoconazole) can raise lacosamide plasma concentrations.

Moderate Interactions (Monitor Closely): - CYP2C19 inhibitors (e.g., fluoxetine) may modestly increase levels. - CYP3A4 inducers (e.g., rifampin) may reduce efficacy. - Other antiepileptics causing sedation may enhance central nervous system depression.